Sky-high for charity
Fasha Mahjoor, Founder and CEO of Phenomenex (Torrance, California, USA), will leap off the 87th floor of The Shard in London on 3 September to raise money for The Outward Bound Trust, an educational charity.
Fasha Mahjoor — Founder and CEO of Phenomenex (Torrance, California, USA) — will leap off the 87th floor of The Shard in London on 3 September to raise money for The Outward Bound Trust, an educational charity. Accompanied by a group, he will abseil down 1,056 feet of the tallest building in Europe: The highest ever attempted descent by a civilian.
Mahjoor’s goal is to raise a minimum of £150,000/€190,000 of which he has personally donated the initial £20,000/€25,000.Led by the Chairman of The Outward Bound Trust, His Royal Highness The Duke of York, Prince Andrew, the charity has enabled over one million underprivileged youths to participate in outdoor programmes, providing important lessons in responsibility, teamwork and leadership.
Mahjoor commented: “Some may think I’ve gone a bit mad to undertake this challenge. But being that it’s for such a wonderful cause that I so very much believe in, I couldn’t possibly turn down the opportunity. To raise money to ensure that this programme continues to impact the lives of many more young people for years to come is simply a privilege.”
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
